Leadership Team

Prior to TrialScope, Jeff was the founder of two successful healthcare technology companies, HeroLinx and Verilogue. HeroLinx is an online crowdsourcing platform for accelerating clinical trial awareness and patient recruiting.  Verilogue, which was acquired by Publicis (PUB:FP), is the global leader in the capture and linguistic analysis of physician-patient exam room dialogues. Jeff also previously served on the Board of Directors for iContracts, a SaaS compliance and revenue management company, and he remains an active angel investor and advisor to a half-dozen software and analytics companies. Jeff holds a BS in Economics from the Wharton School at the University of Pennsylvania, and is the co-author of a method and system patent for analyzing the effectiveness of marketing strategies.

Most recently he served as the COO for Verilogue, a venture-backed tech-enabled research company, with a successful exit in 2013.  

Matt started his career at KPMG spending nearly 5 years performing financial audits on mid-sized public companies.  These companies covered a wide range of industries including software, manufacturing, retail, and hi-tech development.  Matt then moved on to serve 7 years as the Vice President of Finance and Land Development for Pulte Homes, the largest national homebuilder in America, overseeing all finance, legal, HR, and land issues for the Delaware Valley Area.  Matt served as the CFO of STRATIS IoT, a venture-backed software startup, overseeing a Series A capital raise and the implementation of various software solutions including SalesForce.com, Pardot and automated HR tools.  Matt was also the Vice President of Finance at Bohler Engineering overseeing the implementation of a new ERP system covering 13 offices in 7 states.

Matt received a bachelor’s degree in accounting from The Pennsylvania State University and received his CPA license from the state of Pennsylvania (active 2003-2006).

Prior to the acquisition of PharmaCM by TrialScope, Thomas served as the General Manager of PharmaCM at Deloitte and as the Director of PharmaCM Product Management at Intrasphere Technologies. Before joining Intrasphere, Thomas worked in leadership, client-facing positions for Revelwood Inc. and Shepherd Systems, focused on performance management solutions.

Dave’s Life Sciences background includes roles such as Vice President and General Manager of ArisGlobal’s eClinical Business Unit as well as holding a senior level position at eResearchTechnologies, Inc., where he served as the General Manager & Senior Vice President of the eClinical Group. Prior to joining TrialScope, Dave also worked for several early-stage companies where he owned P&L responsibility as a business unit head as well as serving as the President & CEO for a publicly traded company. He has consistently contributed to the development of key areas of the business, including but not limited to, sales and marketing, professional services, product development, customer support, and operations. Dave graduated from Pennsylvania State University with a B.S. in Accounting and a Minor in Economics.

In his role as CTO at TrialScope, Ruben sees himself as an evangelist for vision and innovation, using strategic thinking to anticipate emerging market trends. Over the last 14 years, he has managed both small and large teams at well-respected engineering organizations. Prior to joining TrialScope, Ruben served as Senior Director of Engineering at Medidata Solutions, a software company also catering to the pharmaceutical industry. His previous positions include serving as Senior Consultant for several IT firms and as Vice President of Engineering at Digital Guardian.

He believes that great marketing essentially starts with a clear understanding of customer passions and pain points, and that helping them solve everyday business challenges via thought leadership is the pathway to building value and brand preference.

Naor previously led marketing at remarkable healthcare technology companies, including SmartLinx, CRF Health, and Verilogue.

He holds a B.S. in Marketing from the Rutgers Business School at Rutgers University, and a Marketing Strategy Certification from the Cornell University Samuel Curtis Johnson Graduate School of Management.

Francine also dedicates her time building relationships with external stakeholders – including sponsors, investigators, regulators, and transparency and patient advocates – to help align the goals and expectations of these groups, as well as help identify more consistent ways sponsors can meet industry standards. Prior to her role as Vice President of Global Transparency, Francine served as Director of Product Management at TrialScope. She also serves as Chair of the Drug Information Association (DIA) Clinical Trial Disclosure Community.